XML 39 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (USD $)
Common stock [Member]
Additional paid-in capital [Member]
Retained earnings [Member]
Accumulated other comprehensive income [Member]
Equity Attributable To China Biologic Products, Inc. [Member]
Noncontrolling interest [Member]
Total
Beginning Balance at Dec. 31, 2011 $ 2,560 $ 48,838,311 $ 73,920,811 $ 12,750,682 $ 135,512,364 $ 43,528,677 $ 179,041,041
Beginning Balance (Shares) at Dec. 31, 2011 25,601,125            
Comprehensive income              
Net income     25,796,077   25,796,077 11,514,755 37,310,832
Other comprehensive income       1,061,122 1,061,122 252,013 1,313,135
Stock compensation (ShareBasedCompensation)   1,992,958     1,992,958   1,992,958
Common stock issued in connection with:              
Exercise of warrants 94 8,141,185     8,141,279   8,141,279
Exercise of warrants (Shares) 937,500            
Ending Balance at Jun. 30, 2012 $ 2,654 $ 58,972,454 $ 99,716,888 $ 13,811,804 $ 172,503,800 $ 55,295,445 $ 227,799,245
Ending Balance (Shares) at Jun. 30, 2012 26,538,625